Remove tag health-missions
article thumbnail

Grand Rounds February 2, 2024: Strategies for Improving Public Understanding of FDA and the Products It Regulates…Why Should We Care, and What Might We Do? (Susan C. Winckler, RPh, Esq)

Rethinking Clinical Trials

Food and Drug Administration, FDA, Misinformation, Communication, Health Information Key Points U.S. From January to September 2023, the Foundation conducted in-depth research and held 5 listening sessions to learn how people consume and understand health information. Observation 2: Information vacuums breed misunderstanding.

article thumbnail

Grand Rounds Ethics and Regulatory Series September 9, 2022: Building An Academic Learning Health System: Why Is It So Hard? (Steven Joffe, MD, MPH)

Rethinking Clinical Trials

Department of Medical Ethics & Health Policy. Ethics, Learning Health System. Academic medical institutions may seem like the natural setting to build Learning Health Systems (LHS), but they face unique structural barriers that require leadership, focus, and intentionality to overcome. Art and Ilene Penn Professor and Chair.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Grand Rounds January 26, 2024: Advancing the Safe, Effective and Equitable Use of AI in Healthcare (Mark Sendak, MD, MPP; Suresh Balu, MD, MBA)

Rethinking Clinical Trials

DIHI approaches this work through four pillars of innovation: implementation and health delivery science, health technology innovation, leadership and workforce development, and best practices development and dissemination. The Health AI Partnership started with 7 organization partners and has expanded to about 20 organizations.

article thumbnail

Potential disease-modifying therapy for Parkinson’s disease

Drug Discovery World

The peer-reviewed article titled ‘Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson’s disease (PD) mouse model’ was the result of collaborative work between Cambridge University, Harvard Medical School, and Mission Therapeutics. By inhibiting USP30, MTX325 helps restore normal mitophagy and thus cellular health.

In-Vivo 52
article thumbnail

IBM sells off large parts of Watson Health business

pharmaphorum

A private equity group has agreed to take over most of IBM Watson Health, seven years after the business was launched with a pledge to revolutionise healthcare data analysis. Francisco said in a statement that it offers “a market leading team [that] provides its customers with mission critical products and outstanding service.”

Radiology 109
article thumbnail

Grand Rounds May 5, 2023: All of Us Research Program: Improving Health Through Diverse Technology, Huge Cohorts, and Precision Medicine (Joshua C. Denny, MD, MS)

Rethinking Clinical Trials

Denny, MD, MS CEO, All of Us Research Program Slides Keywords Precision Medicine, All of Us Research Program Key Points The mission of the All of Us Research Program is to accelerate health research and medical breakthroughs, enabling individualized prevention, treatment, and care for all of us.

Medicine 130
article thumbnail

Insights from the 18th Annual Canadian Summit on Food Safety in 2024

XTalks

Related: 4 Reasons to Attend the Upcoming 18th Annual Canadian Summit on Food Safety Day 2 Highlights Day two opened with a keynote from Martin Duplessis of Health Canada, who provided critical updates on food safety practices and regulations, setting a regulatory tone for the day.